Asthika Goonewardene
Stock Analyst at Truist Securities
(1.41)
# 3,471
Out of 4,914 analysts
102
Total ratings
38.46%
Success rate
-10.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $37.39 | +31.05% | 11 | Jul 29, 2025 | |
| GMAB Genmab | Maintains: Buy | $45 → $46 | $22.46 | +104.85% | 15 | Jul 8, 2025 | |
| IGMS IGM Biosciences | Maintains: Hold | $2 → $1 | $1.27 | -21.26% | 9 | Jun 11, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $111.74 | +38.71% | 3 | Jun 3, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $6.84 | +46.20% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $40.65 | +74.66% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.39 | +619.42% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $2.50 | +300.00% | 4 | Apr 1, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $2.70 | +455.56% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.50 | +55.56% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $26.99 | +29.70% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $73.32 | +85.49% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $115.04 | -15.68% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.89 | +1,590.90% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $9.67 | +355.02% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $66.54 | +32.25% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.46 | +174.91% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $2.13 | +794.12% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $0.90 | +4,340.50% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.71 | +3,679.92% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $28.90 | +315.22% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $3.38 | +1,677.78% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $5.14 | +3,401.95% | 4 | Aug 23, 2022 |
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $37.39
Upside: +31.05%
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $22.46
Upside: +104.85%
IGM Biosciences
Jun 11, 2025
Maintains: Hold
Price Target: $2 → $1
Current: $1.27
Upside: -21.26%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $111.74
Upside: +38.71%
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.84
Upside: +46.20%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $40.65
Upside: +74.66%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.39
Upside: +619.42%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.50
Upside: +300.00%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.70
Upside: +455.56%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.50
Upside: +55.56%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $26.99
Upside: +29.70%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $73.32
Upside: +85.49%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $115.04
Upside: -15.68%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.89
Upside: +1,590.90%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $9.67
Upside: +355.02%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $66.54
Upside: +32.25%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.46
Upside: +174.91%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $2.13
Upside: +794.12%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $0.90
Upside: +4,340.50%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.71
Upside: +3,679.92%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $28.90
Upside: +315.22%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $3.38
Upside: +1,677.78%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $5.14
Upside: +3,401.95%